46 related articles for article (PubMed ID: 2908302)
1. Anti-NO action of carvedilol in cell-free system and in vascular endothelial cells.
Yoshioka T; Iwamoto N; Tsukahara F; Irie K; Urakawa I; Muraki T
Br J Pharmacol; 2000 Apr; 129(7):1530-5. PubMed ID: 10742311
[TBL] [Abstract][Full Text] [Related]
2. Perioperative hypertension management.
Varon J; Marik PE
Vasc Health Risk Manag; 2008; 4(3):615-27. PubMed ID: 18827911
[TBL] [Abstract][Full Text] [Related]
3. Effects of carvedilol on serum lipids in hypertensive and normotensive subjects.
Seguchi H; Nakamura H; Aosaki N; Homma Y; Mikami Y; Takahashi S
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S139-42. PubMed ID: 1974504
[TBL] [Abstract][Full Text] [Related]
4. Effects of carvedilol on common carotid arterial flow, peripheral hemodynamics, and hemorheologic variables in hypertension.
Nagakawa Y; Akedo Y; Kaku S; Orimo H
Eur J Clin Pharmacol; 1990; 38 Suppl 2():S115-9. PubMed ID: 1974500
[TBL] [Abstract][Full Text] [Related]
5. Antihypertensive profile of carvedilol.
Meyer-Sabellek W; Agrawal B
Clin Investig; 1992; 70 Suppl 1():S43-52. PubMed ID: 1350484
[TBL] [Abstract][Full Text] [Related]
6. Carvedilol and the kidney.
Dupont AG
Clin Investig; 1992; 70 Suppl 1():S127-31. PubMed ID: 1350479
[TBL] [Abstract][Full Text] [Related]
7. Carvedilol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy.
McTavish D; Campoli-Richards D; Sorkin EM
Drugs; 1993 Feb; 45(2):232-58. PubMed ID: 7681374
[TBL] [Abstract][Full Text] [Related]
8. Analysis of the mechanism underlying the vasodilator action of carvedilol in pithed spontaneously hypertensive rats.
Hashimoto H; Tanaka M; Kanda A; Akashi A
Drugs; 1988; 36 Suppl 6():31-6. PubMed ID: 2908302
[TBL] [Abstract][Full Text] [Related]
9. Vasodilating mechanism and response to physiological pressor stimuli of acute doses of carvedilol compared with labetalol, propranolol and hydralazine.
Tomlinson B; Bompart F; Graham BR; Liu JB; Prichard BN
Drugs; 1988; 36 Suppl 6():37-47. PubMed ID: 2908303
[TBL] [Abstract][Full Text] [Related]
10. Studies on the mechanism of arterial vasodilation produced by the novel antihypertensive agent, carvedilol.
Nichols AJ; Gellai M; Ruffolo RR
Fundam Clin Pharmacol; 1991; 5(1):25-38. PubMed ID: 1712335
[TBL] [Abstract][Full Text] [Related]
11. Features of the acute hypotensive action of carvedilol and its ameliorating effect on myocardial ischemia.
Hashimoto H; Kanda A; Hubo H; Tanaka M
J Cardiovasc Pharmacol; 1991; 18 Suppl 4():S22-8. PubMed ID: 1721975
[TBL] [Abstract][Full Text] [Related]
12. Blood pressure lowering action and alpha-adrenolytic effect of adimolol in rats.
Palluk R; Hoefke W
Arch Int Pharmacodyn Ther; 1989; 301():215-27. PubMed ID: 2576194
[TBL] [Abstract][Full Text] [Related]
13. Alpha-blockade and vasodilatation induced by nipradilol, arotinolol and labetalol in pithed rats.
Nakagawa Y; Nakahara H; Chin WP; Imai S
Jpn J Pharmacol; 1985 Dec; 39(4):481-5. PubMed ID: 2419612
[TBL] [Abstract][Full Text] [Related]
14. Direct vasodilatation by labetalol in anaesthetized dogs.
Dage RC; Hsieh CP
Br J Pharmacol; 1980 Oct; 70(2):287-93. PubMed ID: 7426837
[TBL] [Abstract][Full Text] [Related]
15. Haemodynamic effects of carvedilol, a new beta-adrenoceptor blocker and precapillary vasodilator in essential hypertension.
Eggertsen R; Sivertsson R; Andrén L; Hansson L
J Hypertens; 1984 Oct; 2(5):529-34. PubMed ID: 6152280
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
